<DOC>
	<DOCNO>NCT02011386</DOCNO>
	<brief_summary>The study investigate different criterion remission base MRI circulate biomarkers inflammation , cartilage , connective tissue bone turnover patient axial spondyloarthritis treat Golimumab . Furthermore , study also investigate factor affect disease activity , function participation use different questionnaire .</brief_summary>
	<brief_title>Novel MRI ANd Biomarkers GOlimumab-treated Patients With Axial Spondyloarthritis</brief_title>
	<detailed_description />
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Axial spondyloarthritis accord ASAS classification criterion Sacroiliitis conventional Xrays MRI . Disease activity assess BASDAI &gt; 40 mm despite treatment NSAID . Clinical indication tumornecrosisfactoralpha inhibitor treatment treat physician . No contraindication tumornecrosisfactoralpha inhibitor No contraindication MRI No contraindication participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>